Skip to main content

A study identifies a new mechanism that contributes to the development of colon cancer

16 Jul 18




Press and Communications Officer
Tel.+34 93 40 37255

La Razón, Al Día, Cope, Medical News Today, Medical Xpress, among other national and international media, have published articles about the research led by Angel R. Nebreda, head of the Cell Signalling and Cell Cycle Lab at IRB Barcelona. This study identifies a new mechanism that contributes to the development of inflammation-associated colon cancer and proposes new therapeutic approaches.

Link to Al Día

Link to Cope

Link to Medical News Today

Link to Medical Xpress


About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).